Personal information

Websites & social links

http://www.amyloidosis.it

Other IDs

ResearcherID: G-1763-2010
Scopus Author ID: 7006442443

Keywords

amyloidosis

Countries

Italy

Activities

Collapse all

Employment (6)

Fondazione IRCCS Policlinico San Matteo: Pavia, Pavia, IT

2021-04-21 to present | Director (Amyloidosis Research and Treatment Center)
Employment
Source: Self-asserted source
Giovanni Palladini

Università degli Studi di Pavia: Pavia, Lombardia, IT

2019-12-31 to present | Full professor of Clinical Chemistry (Molecular Medicine)
Employment
Source: Self-asserted source
Giovanni Palladini

Fondazione IRCCS Policlinico San Matteo: Pavia, IT

2016-04-20 to 2021-04-20 | Acting Director (Biotechemistry, Biotechnology and Advanced Diagnostics Laboratory and Amyloidosis Research and Treatment Center)
Employment
Source: Self-asserted source
Giovanni Palladini

Università degli Studi di Pavia: Pavia, Lombardia, IT

2015-05-13 to 2019-12-30 | Associate Professor of Clinical Chemistry (Molecular Medicine)
Employment
Source: Self-asserted source
Giovanni Palladini

Fondazione IRCCS Policlinico San Matteo: Pavia, Lombardia, IT

1997 to 2016-04-19 (Amyloidosis Research and Treatment Center)
Employment
Source: Self-asserted source
Giovanni Palladini

Università degli Studi di Pavia: Pavia, Lombardia, IT

2008 to 2015 | Assistant Professor of Clinical Chemistry (Molecular Medicine)
Employment
Source: Self-asserted source
Giovanni Palladini

Education and qualifications (2)

Università degli Studi di Pavia: Pavia, Lombardia, IT

2002 to 2007 | PhD
Education
Source: Self-asserted source
Giovanni Palladini

Università degli Studi di Pavia: Pavia, Lombardia, IT

1991 to 1997 | MD
Education
Source: Self-asserted source
Giovanni Palladini

Professional activities (5)

Italian Society of Clinical Biochemistry: Milan, IT

2021 to present | Coordinator of the Scientific Division
Service
Source: Self-asserted source
Giovanni Palladini

International Society of Amyloidosis: Rochester, MN, US

2020 to present | President
Service
Source: Self-asserted source
Giovanni Palladini

International Society of Amyloidosis: Rochester, MN, US

2018 to 2020 | Vice President
Service
Source: Self-asserted source
Giovanni Palladini

International Society of Amyloidosis: Rochester, MN, US

2016 to 2018 | Secretary
Service
Source: Self-asserted source
Giovanni Palladini

International Society of Amyloidosis: Rochester, MN, US

2010 to 2014 | Member at Large
Service
Source: Self-asserted source
Giovanni Palladini

Works (50 of 209)

Items per page:
Page 1 of 5

AL or ATTR Amyloidosis? Never Two Without Three

Circulation
2025-01-21 | Journal article
DOI: 10.1161/CIRCULATIONAHA.124.072460
Contributors: Mario Nuvolone; Giuseppe D. Sanna; Giovanni Palladini
Source: check_circle
Crossref

Response matters in light chain amyloidosis, whatever it takes

British Journal of Haematology
2024-07 | Journal article
DOI: 10.1111/bjh.19581
Contributors: Giovanni Palladini; Paolo Milani
Source: check_circle
Crossref

Modeling immunoglobulin light chain amyloidosis inCaenorhabditis elegans

2024-07-09 | Preprint
DOI: 10.1101/2024.07.05.602215
Contributors: Margherita Romeo; Maria Monica Barzago; Alessandro Corbelli; Silvia Maglioni; Natascia Ventura; Carmina Natale; Andrea Conz; Mario Salmona; Giovanni Palladini; Mario Nuvolone et al.
Source: check_circle
Crossref

SMaRT M-Seq: an optimized step-by-step protocol for M protein sequencing in monoclonal gammopathies

Biology Methods and Protocols
2024-01-11 | Journal article
DOI: 10.1093/biomethods/bpae074
Contributors: Alice Nevone; Francesca Lattarulo; Monica Russo; Pasquale Cascino; Giampaolo Merlini; Giovanni Palladini; Mario Nuvolone
Source: check_circle
Crossref

A Strategy for the Selection of RT-qPCR Reference Genes Based on Publicly Available Transcriptomic Datasets

Biomedicines
2023-04-03 | Journal article
DOI: 10.3390/biomedicines11041079
Contributors: Alice Nevone; Francesca Lattarulo; Monica Russo; Giada Panno; Paolo Milani; Marco Basset; Maria Antonietta Avanzini; Giampaolo Merlini; Giovanni Palladini; Mario Nuvolone
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Venetoclax in Relapse/Refractory AL Amyloidosis—A Multicenter International Retrospective Real-World Study

Cancers
2023-03-10 | Journal article
DOI: 10.3390/cancers15061710
Contributors: Eyal Lebel; Efstathios Kastritis; Giovanni Palladini; Paolo Milani; Foteini Theodorakakou; Shlomzion Aumann; Noa Lavi; Liat Shargian; Hila Magen; Yael Cohen et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis

Journal of Clinical Oncology
2023-03-01 | Journal article
DOI: 10.1200/JCO.22.00643
Contributors: Eli Muchtar; Angela Dispenzieri; Brendan Wisniowski; Giovanni Palladini; Paolo Milani; Giampaolo Merlini; Stefan Schönland; Kaya Veelken; Ute Hegenbart; Susan M. Geyer et al.
Source: check_circle
Crossref

Diagnosis and Treatment of AL Amyloidosis

Drugs
2023-02 | Journal article
DOI: 10.1007/s40265-022-01830-z
Contributors: Giovanni Palladini; Paolo Milani
Source: check_circle
Crossref

The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018

Blood Cancer Journal
2023-01-25 | Journal article
DOI: 10.1038/s41408-023-00789-8
Contributors: Giovanni Palladini; Stefan Schönland; Giampaolo Merlini; Paolo Milani; Arnaud Jaccard; Frank Bridoux; Meletios A. Dimopoulos; Sriram Ravichandran; Ute Hegenbart; Wilfried Roeloffzen et al.
Source: check_circle
Crossref

Early cardiac response is possible in stage IIIb cardiac AL amyloidosis and is associated with prolonged survival

Blood
2022-11-03 | Journal article
DOI: 10.1182/blood.2022016348
Contributors: Marco Basset; Paolo Milani; Andrea Foli; Mario Nuvolone; Pietro Benvenuti; Martina Nanci; Francesca Fabris; Claudia Bellofiore; Giampaolo Merlini; Giovanni Palladini
Source: check_circle
Crossref

How I treat AL amyloidosis

Blood
2022-05-12 | Journal article
DOI: 10.1182/blood.2020008737
Contributors: Giovanni Palladini; Giampaolo Merlini
Source: check_circle
Crossref

Cu(II) Binding Increases the Soluble Toxicity of Amyloidogenic Light Chains

International Journal of Molecular Sciences
2022-01-16 | Journal article
DOI: 10.3390/ijms23020950
Contributors: Rosaria Russo; Margherita Romeo; Tim Schulte; Martina Maritan; Luca Oberti; Maria Monica Barzago; Alberto Barbiroli; Carlo Pappone; Luigi Anastasia; Giovanni Palladini et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Two-hit strategy for treating AL amyloidosis?

Blood
2021-12-23 | Journal article
DOI: 10.1182/blood.2021013817
Contributors: Giampaolo Merlini; Giovanni Palladini
Source: check_circle
Crossref

Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis

Blood Cancer Journal
2021-02-16 | Journal article
DOI: 10.1038/s41408-021-00428-0
Contributors: Giovanni Palladini; Bruno Paiva; Ashutosh Wechalekar; Margherita Massa; Paolo Milani; Marta Lasa; Sriram Ravichandran; Isabel Krsnik; Marco Basset; Leire Burgos et al.
Source: check_circle
Crossref

Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosis

Blood Advances
2020-09-08 | Journal article
DOI: 10.1182/bloodadvances.2020002219
Contributors: Marco Basset; Paolo Milani; Mario Nuvolone; Francesca Benigna; Lara Rodigari; Andrea Foli; Giampaolo Merlini; Giovanni Palladini
Source: check_circle
Crossref

Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy

Blood Cancer Journal
2020-09-01 | Journal article
DOI: 10.1038/s41408-020-00355-6
Contributors: Paolo Milani; Marco Basset; Mario Nuvolone; Francesca Benigna; Lara Rodigari; Francesca Lavatelli; Andrea Foli; Giampaolo Merlini; Giovanni Palladini
Source: check_circle
Crossref

Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA

Blood
2020-07-02 | Journal article
DOI: 10.1182/blood.2019004460
Contributors: Giovanni Palladini; Efstathios Kastritis; Mathew S. Maurer; Jeffrey Zonder; Monique C. Minnema; Ashutosh D. Wechalekar; Arnaud Jaccard; Hans C. Lee; Naresh Bumma; Jonathan L. Kaufman et al.
Source: check_circle
Crossref

A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis

Blood
2020-04-30 | Journal article
DOI: 10.1182/blood.2019004369
Contributors: Murielle Roussel; Giampaolo Merlini; Sylvie Chevret; Bertrand Arnulf; Anne Marie Stoppa; Aurore Perrot; Giovanni Palladini; Lionel Karlin; Bruno Royer; Antoine Huart et al.
Source: check_circle
Crossref

A new genetic variant of hereditary apolipoprotein A-I amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic options

Bmc Medical Genetics
2019 | Journal article
DOI: 10.1186/s12881-019-0755-5
WOSUID:

WOS:000458066000002
Contributors: Moutafi, Myrto; Ziogas, Dimitrios C.; Michopoulos, Spyros; Bagratuni, Tina; Vasileiou, Vassiliki; Verga, Laura; Merlini, Giampaolo; Palladini, Giovanni; Matsouka, Charis; Dimopoulos, Meletios A. et al.
Source: Self-asserted source
Giovanni Palladini via ResearcherID

ATR-FTIR Spectroscopy Supported by Multivariate Analysis for the Characterization of Adipose Tissue Aspirates from Patients Affected by Systemic Amyloidosis

Analytical Chemistry
2019 | Journal article
DOI: 10.1021/acs.analchem.8b05008
WOSUID:

WOS:000459642400046
Contributors: Ami, Diletta; Mereghetti, Paolo; Foli, Andrea; Tasaki, Masayoshi; Milani, Paolo; Nuvolone, Mario; Palladini, Giovanni; Merlini, Giampaolo; Lavatelli, Francesca; Natalello, Antonino
Source: Self-asserted source
Giovanni Palladini via ResearcherID

Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient

Nature Communications
2019 | Journal article
DOI: 10.1038/s41467-019-09133-w
WOSUID:

WOS:000461757400007
Contributors: Swuec, Paolo; Lavatelli, Francesca; Tasaki, Masayoshi; Paissonil, Cristina; Rognoni, Paola; Maritanl, Martina; Brambilla, Francesca; Milani, Paolo; Mauri, Pierluigi; Camilloni, Carlo et al.
Source: Self-asserted source
Giovanni Palladini via ResearcherID

When should treatment of AL amyloidosis start at relapse? Early, to prevent organ progression

Blood Advances
2019-01-22 | Journal article
DOI: 10.1182/bloodadvances.2018021253
Contributors: Giovanni Palladini; Giampaolo Merlini
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

AMYLOID LIGHT-CHAIN AMYLOIDOSIS: ESTABLISHED AND NOVEL THERAPIES

Haematologica
2018 | Journal article
WOSUID:

WOS:000431395800019
Contributors: Palladini, G.; Basset, M.
Source: Self-asserted source
Giovanni Palladini via ResearcherID

Growth Differentiation Factor 15 Is a New Biomarker for Survival and Renal Outcomes in Light Chain (AL) Amyloidosis.

Blood
2018 | Journal article
DOI: 10.1182/blood-2017-12-819904
WOSUID:

MEDLINE:29386197
Contributors: Kastritis, Efstathios; Papassotiriou, Ioannis; Merlini, Giampaolo; Milani, Paolo; Terpos, Evangelos; Basset, Marco; Akalestos, Athanasios; Russo, Francesca; Psimenou, Erasmia; Apostolakou, Filia et al.
Source: Self-asserted source
Giovanni Palladini via ResearcherID

GWAS of Immunoglobulin light chain (AL) amyloidosis

GWAS Central
2018 | Other
WOSUID:

DRCI:DATA2018225014742641
Contributors: Da Silva Filho, MI; Forsti, A; Weinhold, N; Meziane, I; Campo, C; Huhn, S; Nickel, J; Hoffmann, P; Nothen, MM; Jockel, KH et al.
Source: Self-asserted source
Giovanni Palladini via ResearcherID

GWAS of Immunoglobulin light chain amyloidosis

GWAS Central
2018 | Other
WOSUID:

DRCI:DATA2018225014743010
Contributors: Meziane, I; Huhn, S; Filho, MIDS; Weinhold, N; Campo, C; Nickel, J; Hoffmann, P; Nothen, MM; Jockel, KH; Landi, S et al.
Source: Self-asserted source
Giovanni Palladini via ResearcherID

Hematologic Responses in Patients with Heavily Pretreated Light Chain Deposition Disease (LCDD) Receiving Daratumumab

Blood
2018 | Journal article
DOI: 10.1182/blood-2018-99-118108
WOSUID:

WOS:000454837605313
Contributors: Milani, Paolo; Basset, Marco; Foli, Andrea; Merlini, Giampaolo; Palladini, Giovanni
Source: Self-asserted source
Giovanni Palladini via ResearcherID

Light Chain Amyloidosis

Mediterranean Journal of Hematology and Infectious Diseases
2018 | Journal article
DOI: 10.4084/MJHID.2018.022
WOSUID:

WOS:000428337200006
Contributors: Milani, Paolo; Merlini, Giampaolo; Palladini, Giovanni
Source: Self-asserted source
Giovanni Palladini via ResearcherID

Light Chain Amyloidosis and Non-Hodgkins Lymphomas: A Peculiar Association with Distinct Clinical Features and Outcome

Blood
2018 | Journal article
DOI: 10.1182/blood-2018-99-118161
WOSUID:

WOS:000454837606024
Contributors: Basset, Marco; Defrancesco, Irene; Milani, Paolo; Rattotti, Sara; Foli, Andrea; Varettoni, Marzia; Corso, Alessandro; Paulli, Marco; Merlini, Giampaolo; Arcaini, Luca et al.
Source: Self-asserted source
Giovanni Palladini via ResearcherID

Management of the elderly patient with AL amyloidosis.

European journal of internal medicine
2018 | Journal article
DOI: 10.1016/j.ejim.2018.05.004
WOSUID:

MEDLINE:29801808
Contributors: Nuvolone, Mario; Milani, Paolo; Palladini, Giovanni; Merlini, Giampaolo
Source: Self-asserted source
Giovanni Palladini via ResearcherID

New concepts in the treatment and diagnosis of amyloidosis

Expert Review of Hematology
2018 | Journal article
DOI: 10.1080/17474086.2018.1424534
WOSUID:

WOS:000423476900005
Contributors: Milani, Paolo; Palladini, Giovanni; Merlini, Giampaolo
Source: Self-asserted source
Giovanni Palladini via ResearcherID

Novel Therapies in Light Chain Amyloidosis

Kidney International Reports
2018 | Journal article
DOI: 10.1016/j.ekir.2017.11.017
WOSUID:

WOS:000432471300006
Contributors: Milani, Paolo; Merlini, Giampaolo; Palladini, Giovanni
Source: Self-asserted source
Giovanni Palladini via ResearcherID

OUTCOME OF ELDERLY PATIENTS WITH LIGHT CHAIN AL AMYLOIDOSIS

Haematologica
2018 | Journal article
WOSUID:

WOS:000431395800032
Contributors: Milani, P.; Basset, M.; Nuvolone, M.; Mussinelli, R.; Perlini, S.; Foli, A.; Palladini, G.; Merlini, G.
Source: Self-asserted source
Giovanni Palladini via ResearcherID

Pomalidomide and Dexamethasone Grant Rapid Hematologic Responses in Patients with Relapsed and Refractory AL Amyloidois: A European Retrospective Series of 150 Patients

Blood
2018 | Journal article
DOI: 10.1182/blood-2018-99-118034
WOSUID:

WOS:000454842801068
Contributors: Milani, Paolo; Sharpley, Faye; Schoenland, Stefan; Basset, Marco; Mahmood, Shameem; Kimmich, Christoph; Foli, Andrea; Sachchithanantham, Sajitha; Merlini, Giampaolo; Wechalekar, Ashutosh D. et al.
Source: Self-asserted source
Giovanni Palladini via ResearcherID

Systemic immunoglobulin light chain amyloidosis

Nature Reviews Disease Primers
2018 | Journal article
DOI: 10.1038/s41572-018-0034-3
WOSUID:

WOS:000448497700001
Contributors: Merlini, Giampaolo; Dispenzieri, Angela; Sanchorawala, Vaishali; Schoenland, Stefan O.; Palladini, Giovanni; Hawkins, Philip N.; Gertz, Morie A.
Source: Self-asserted source
Giovanni Palladini via ResearcherID

TREATMENT WITH POMALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH LIGHT CHAIN AL AMYLOIDOSIS AND MULTIPLE MYELOMA

Haematologica
2018 | Journal article
WOSUID:

WOS:000431395800093
Contributors: Basset, M.; Milani, P.; Foli, A.; Merlini, G.; Palladini, G.
Source: Self-asserted source
Giovanni Palladini via ResearcherID

What does minimal residual disease mean in AL amyloidosis?

Expert Opinion on Orphan Drugs
2018 | Journal article
DOI: 10.1080/21678707.2018.1549482
WOSUID:

WOS:000452789500001
Contributors: Milani, Paolo; Merlini, Giampaolo; Palladini, Giovanni
Source: Self-asserted source
Giovanni Palladini via ResearcherID

Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p

Clinical Lymphoma Myeloma and Leukemia
2018-11 | Journal article
DOI: 10.1016/j.clml.2018.07.292
Contributors: Sandy W. Wong; Ute Hegenbart; Giovanni Palladini; Gunjan L. Shah; Heather J. Landau; Melissa Warner; Denis Toskic; Arnaud Jaccard; Timon Hansen; Joan Bladé et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Treatment of AL amyloidosis with bendamustine: a study of 122 patients

Blood
2018-11-01 | Journal article
DOI: 10.1182/blood-2018-04-845396
Contributors: Paolo Milani; Stefan Schönland; Giampaolo Merlini; Christoph Kimmich; Andrea Foli; Tobias Dittrich; Marco Basset; Carsten Müller-Tidow; Tilmann Bochtler; Giovanni Palladini et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

The elusive pathogenesis of Schnitzler syndrome

Blood
2018-03-01 | Journal article
DOI: 10.1182/blood-2018-01-824862
Contributors: Giovanni Palladini; Giampaolo Merlini
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Presentation and outcome with second-line treatment in AL amyloidosis previously sensitive to nontransplant therapies

Blood
2018-02-01 | Journal article
DOI: 10.1182/blood-2017-04-780544
Contributors: Giovanni Palladini; Paolo Milani; Andrea Foli; Marco Basset; Francesca Russo; Stefano Perlini; Giampaolo Merlini
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis

Blood
2017 | Journal article
DOI: 10.1182/blood-2017-03-771220
WOSUID:

WOS:000406875400008
Contributors: Sanchorawala, Vaishali; Palladini, Giovanni; Kukreti, Vishal; Zonder, Jeffrey A.; Cohen, Adam D.; Seldin, David C.; Dispenzieri, Angela; Jaccard, Arnaud; Schoenland, Stefan O.; Berg, Deborah et al.
Source: Self-asserted source
Giovanni Palladini via ResearcherID

A Prospective Phase II of Daratumumab in Previously-Treated Systemic Light-Chain (AL) Amyloidosis

Blood
2017 | Journal article
WOSUID:

WOS:000432419401156
Contributors: Roussel, Murielle; Stoppa, Anne-Marie; Perrot, Aurore; Karlin, Lionel; Arnulf, Bertrand; Macro, Margaret; Huart, Antoine; Frenzel, Laurent; Morel, Pierre; Boyle, Eileen et al.
Source: Self-asserted source
Giovanni Palladini via ResearcherID

BDR in newly diagnosed patients with WM: Final analysis of a phase 2 study after a minimum follow-up of 6 years

Blood
2017 | Journal article
DOI: 10.1182/blood-2016-09-742411
EID:

2-s2.0-85014945676
Contributors: Gavriatopoulou, M.; García-Sanz, R.; Kastritis, E.; Morel, P.; Kyrtsonis, M.-C.; Michalis, E.; Kartasis, Z.; Leleu, X.; Palladini, G.; Tedeschi, A. et al.
Source: Self-asserted source
Giovanni Palladini via Scopus - Elsevier
grade
Preferred source (of 2)‎

Biomarker-Based Screening of Organ Dysfunction in Patients with MGUS Allows Early Diagnosis of AL Amyloidosis

Blood
2017 | Journal article
WOSUID:

WOS:000432419404204
Contributors: Palladini, Giovanni; Basset, Marco; Milani, Paolo; Varettoni, Marzia; Mangiacavalli, Silvia; Russo, Francesca; Foli, Andrea; Corso, Alessandro; Merlini, Giampaolo
Source: Self-asserted source
Giovanni Palladini via ResearcherID

Cardiac light chain amyloidosis: The role of metal ions in oxidative stress and mitochondrial damage.

Antioxidants & redox signaling
2017 | Journal article
DOI: 10.1089/ars.2016.6848
WOSUID:

MEDLINE:28132512
Contributors: Diomede, Luisa; Romeo, Margherita; Rognoni, Paola; Beeg, Marten; Foray, Claudia; Ghibaudi, Elena; Palladini, Giovanni; Cherny, Robert Alan; Verga, Laura; Capello, Gian Luca et al.
Source: Self-asserted source
Giovanni Palladini via ResearcherID

Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays

Clinical Chemistry and Laboratory Medicine
2017 | Journal article
DOI: 10.1515/cclm-2016-1024
WOSUID:

WOS:000412444600024
Contributors: Palladini, Giovanni; Jaccard, Arnaud; Milani, Paolo; Lavergne, David; Foli, Andrea; Bender, Sebastien; Lavatelli, Francesca; Bosoni, Tiziana; Valentini, Veronica; Pirolini, Laura et al.
Source: Self-asserted source
Giovanni Palladini via ResearcherID

EVALUATION OF GROWTH DIFFERENTIATION FACTOR-1 (GDF15) AS A NEW BIOMARKER FOR RENAL OUTCOMES IN DIFFERENT COHORTS OF PATIENTS WITH LIGHT CHAIN AMYLOIDOSIS

Haematologica
2017 | Journal article
WOSUID:

WOS:000404127001232
Contributors: Kastritis, E.; Papassotiriou, I.; Merlini, G.; Milani, P.; Terpos, E.; Basset, M.; Akalestos, A.; Russo, F.; Psimenou, E.; Apostolakou, F. et al.
Source: Self-asserted source
Giovanni Palladini via ResearcherID

Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts

Haematologica
2017 | Journal article
DOI: 10.3324/haematol.2017.171108
WOSUID:

WOS:000411964200010
Contributors: Meziane, Iman; Huhn, Stefanie; da Silva Filho, Miguel Inacio; Weinhold, Niels; Campo, Chiara; Nickel, Jolanta; Hoffmann, Per; Noethen, Markus M.; Joeckel, Karl-Heinz; Landi, Stefano et al.
Source: Self-asserted source
Giovanni Palladini via ResearcherID

Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma

Leukemia
2017 | Journal article
DOI: 10.1038/leu.2016.387
EID:

2-s2.0-85009391388
Contributors: da Silva Filho, M.I.; Försti, A.; Weinhold, N.; Meziane, I.; Campo, C.; Huhn, S.; Nickel, J.; Hoffmann, P.; Nöthen, M.M.; Jöckel, K.-H. et al.
Source: Self-asserted source
Giovanni Palladini via Scopus - Elsevier
grade
Preferred source (of 2)‎
Items per page:
Page 1 of 5

Peer review (9 reviews for 6 publications/grants)

Review activity for International journal of cardiology. (3)
Review activity for Leukemia (1)
Review activity for Orphanet journal of rare diseases. (2)
Review activity for Quality of life research. (1)
Review activity for The lancet. (1)
Review activity for Transplantation reviews. (1)
How many people are using ORCID?